|
Medical technology maker Covidien PLC was awarded $176.5 million in a patent infringement suit with Ethicon Endo-Surgery Inc., a Johnson & Johnson company.
more
By PBN Staff
|
|
Lifespan opened a new stem cell research laboratory Wednesday afternoon on the fifth floor of the hospital network’s Coro Building. The lab is the first phase of a major investment to turn the entire building in Providence’s Knowledge District into a state-of-the art research facility.
more
By Richard Asinof |
|
More than 470 girls from local high schools spent Thursday at the University of Rhode Island exploring STEM industries and career pathways during Tech Collective’s 12th annual GRRL Tech event.
more
By Lindsay Lorenz |
|
Nabsys Inc., a life sciences company focused on the creation of a single-molecule platform for genomic analysis, has closed a $20 million Series D financing round, the company announced Wednesday.
more
By Emily Greenhalgh |
|
Tech Collective, Rhode Island’s bioscience and IT industry association, has announced the six winners of its inaugural Rhode Island Bioscience Awards.
more
By PBN Staff
|
|
he Rhode Island Tech Collective announced last week that “science-centric” comedian Brian Malow is slated to perform at its inaugural Bioscience Awards celebration.
more
By Alex Kowalski |
|
(Updated, 1:18 p.m.)
Biomedical Structures LLC, the developer of biomedical textiles for medical devices, has merged with Modified Polymer Components, a Sunnyvale, Calif.-based company specializing in the design, rapid prototyping and manufacture of polymer components for medical device original equipment manufacturers.
more
By PBN Staff
|
|
Medical technology maker Covidien PLC reported first-quarter earnings of $493 million, or $1.03 per diluted share, a slight decrease from the $494 million, or $1.02 per diluted share, reported for the first-quarter of its fiscal 2012.
more
By PBN Staff
|
|
Amgen Inc., one of the world’s largest biotechnology companies, reported fourth-quarter profit that beat analyst estimates as sales of arthritis and bone drugs rose.
more
By Ryan Flinn |
|
Amgen Inc., one of the world’s largest biotechnology companies, plans to invest $200 million on a new manufacturing facility in Singapore.
more
By Alex Kowalski |